The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation

Molecular and Cellular Biology

Volumn 24, Issue 17, 2004, Pages 7514-7523

  García Silva, Susana ^a   Aranda, Ana ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION TRANSCRIPTION FACTOR 2; B ZIP TRANSCRIPTION FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN D1; ISOPROTEIN; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; S6 KINASE; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; EMBRYO; FIBROBLAST; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUDE MOUSE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; FIBROSARCOMA; GENE EXPRESSION REGULATION; GENES, RAS; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; PROTEIN KINASES; RECEPTORS, THYROID HORMONE; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE;

ANIMALIA; MUS MUSCULUS;

EID: 4344598164     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.17.7514-7523.2004     Document Type: Article

References (51)

1. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
2. Aranda, A., and A. Pascual. 2001. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:1269-1304.
3. Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
4. Brown, J. R., E. Nigh, R. J. Lee, H. Ye, M. A. Thompson, F. Saudou, R. G. Pestell, and M. E. Greenberg. 1998. Fos family members induce cell cycle entry by activating cyclin D1. Mol. Cell. Biol. 18:5609-5619.
5. Crespo, P., and J. Leon. 2000. Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol. Life Sci. 57:1613-1636.
6. Davis, P. J., A. Shih, H. Y. Lin, L. J. Martino, and F. B. Davis. 2000. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J. Biol. Chem. 275:38032-38039.
7. Drabkin, H., F.-T. Kao, J. Hartz, I. Hart, A. Gazdar, C. Weinberger, R. Evans., and M. Gerber. 1988. Localization of human ERBA2 to the 3p22-3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc. Natl. Acad. Sci. USA 85:9258-9262.
8. Filmus, J., A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo, and C. J. Conti. 1994. Induction of cyclin D1 overexpression by activated ras. Oncogene 9:3627-3633.
9. 1 cell cycle progression. J. Biol. Chem. 274:22033-22040.
10. Gonzalez-Sancho, J. M., V. Garcia, F. Bonilla, and A. Munoz. 2003. Thyroid hormone receptors/THR genes in human cancer. Cancer Lett. 192:121-132.
11. Gottlicher, M., S. Heck, and P. Herrlich. 1998. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76:480-489.
12. Henry, D. O., S. A. Moskalenko, K. J. Kaur, M. Fu, R. G. Pestell, J. H. Camonis, and M. A. White. 2000. Ral GTPases contribute to regulation of cyclin D1 through activation of NF-κB. Mol. Cell. Biol. 20:8084-8092.
13. Herber, B., M. Truss, M. Beato, and R. Muller. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295-1304.
14. Hong, S. H., and M. L. Privalsky. 2000. The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol. Cell. Biol. 20:6612-6625.
15. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 21:869-883.
16. Kamiya, Y., M. Puzianowska-Kuznicka, P. McPhie, J. Nauman, S.-Y. Cheng, and A. Nauman. 2002. Expression of mutant thyroid hormone receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23:25-33.
17. Karin, M., and L. Chang. 2001. AP-1-glucocorticoid receptor cross talk taken to a higher level. J. Endocrinol. 169:447-451.
18. Lebel, J. M., J. H. Dussault, and J. Puymirat. 1994. Overexpression of the beta 1 thyroid receptor induces differentiation in neuro-2a cells. Proc. Natl. Acad. Sci. USA 91:2644-2648.
19. v-src signaling in breast cancer cells. J. Biol. Chem. 274:7341-7350.
20. Li, Z., Z. H. Meng, R. Chandrasekaran, W.-L. Kuo, C. C. Collins, J. W. Gray, and S. H. Diarkee. 2002. Biallelic inactivation of the thyroid hormone receptor β1 gene in early stage breast cancer. Cancer Res. 62:1939-1943.
21. Lin, K. H., H. Y. Shieh, S. L. Chen, and H. C. Hsu. 1999. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol. Carcinog. 26:53-61.
22. 1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
23. Lowy, D. R., and B. M. Willumsem. 1993. Function and regulation of ras. Annu. Rev. Biochem. 62:851-891.
24. Markowitz, S., M. Haut, T. Stellato, C. Gerbic, and K. Molkentin. 1989. Expression of the ErbA-β class of thyroid hormone receptors is selectively lost in human colon carcinoma. J. Clin. Investig. 84:1683-1687.
25. Mendez-Pertuz, M., A. Sanchez-Pacheco, and A. Aranda. 2003. The thyroid hormone receptor antagonizes CREB-mediated transcription. EMBO J. 22: 3102-3112.
26. Nagata, D., E. Suzuki, H. Nishimatsu, H. Satonak, A. Goto, M. Omata, and Y. Hirata. 2001. Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells. J. Biol. Chem. 276:662-669.
27. rsk. Cell 86:465-474.
28. Nissen, R. M., and K. R. Yamamoto. 2000. The glucocorticoid receptor inhibits NF-κB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14:2314-2329.
29. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386:177-181.
30. Kip1 is involved in thyroid hormone-mediated neuronal differentiation. J. Biol. Chem. 274:5026-5031.
31. Perez-Juste, G., S. Garcia-Silva, and A. Aranda. 2000. An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells. J. Biol. Chem. 275:1307-1314.
32. Pfahl, M. 1993. Nuclear receptor/AP-1 interaction. Endocrinol. Rev. 14:651-658.
33. Qureshi, S. A., K. Alexandropoulos, M. Rim, C. K. Joseph, J. T. Bruder, U. R. Rapp, and D. A. Foster. 1992. Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src. J. Biol. Chem. 267: 17635-17639.
34. Riley, D., N. O. Carragher, M. C. Frame, and J. A. Wyke. 2001. The mechanism of cell cycle regulation by v-Src. Oncogene 20:5941-5950.
35. Robles, A. I., M. L. Rodriguez-Puebla, A. B. Glick, C. Trempus, L. Hansen, P. Sicinski, R. W. Tennant, R. A. Weinberg, S. H. Yuspa, and C. J. Conti. 1998. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev. 12:2469-2474.
36. Rogatsky, I., K. A. Zarember, and K. R. Yamamoto. 2001. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. 20: 6071-6083.
37. Rowan, B. G., N. Garrison, N. L. Weigel, and B. W. O'Malley. 2000. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB-binding protein. Mol. Cell. Biol. 20:8720-8730.
38. Sanchez-Pacheco, A., T. Palomino, and A. Aranda. 1995. Negative regulation of expression of the pituitary-specific transcription factor GHF-1/Pit-1 by thyroid hormones through interference with promoter enhancer elements. Mol. Cell. Biol. 15:6322-6330.
39. Sap, J., A. Munoz, J. Schmitt, H. Stunnenberg, and B. Vennstrom. 1989. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature 340:242-244.
40. Sassone-Corsi, P., C. A. Mizzen, P. Cheung, C. Crosio, L. Monaco, S. Jacquot, A. Hanauer, and C. D. Allis. 1999. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285:886-891.
41. Shaywitz, A. J., and M. E. Greenberg. 1999. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:821-861.
42. Silva, J. M., G. Dominguez, J. M. Gonzalez-Sancho, J. M. Garcia, J. Silva, C. Garcia-Andrade, A. Navarro, A. Munoz, and F. Bonilla. 2002. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 21:4307-4316.
43. Stacey, D. W., M. Roudebush, R. Day, S. D. Mosser, J. B. Gibbs, and L. A. Feig. 1991. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine oncogenes. Oncogene 6:2297-2304.
44. Suzuki, H., M. C. Willingham, and S.-Y. Cheng. 2002. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12:963-969.
45. Thormeyer, D., and A. Baniahmad. 1999. The v-erbA oncogene. Int. J. Mol. Med. 4:351-358.
46. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
47. Weber, J. D., W. Hu, S. C. Jefcoat, Jr., D. M. Raben, and J. J. Baldassare. 1997. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272:32966-32971.
48. Xing, J., D. D. Ginty, and M. E. Greenberg. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273:959-963.
49. Yen, P. M. 2001. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81:1097-1142.
50. Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1020.
51. rsk isoforms with mitogen-activated protein kinases. J. Biol. Chem. 271: 29773-29779.